Can you provide a SOAP note for an adult patient with a history of cholecystectomy who presents with acid reflux, dyspepsia, and intermittent tingling of the face and hands?

SOAP Note: Adult Patient with Acid Reflux, Dyspepsia, and Paresthesias Post-Cholecystectomy

Subjective

Chief Complaint: Acid reflux, indigestion, and tingling of face and hands

History of Present Illness:

• Duration, frequency, and severity of acid reflux symptoms (heartburn, regurgitation)
• Timing of dyspeptic symptoms (epigastric pain, bloating, early satiety, postprandial fullness)
• Relationship of symptoms to meals and body position
• Duration and pattern of face and hand tingling (intermittent vs. constant, unilateral vs. bilateral)
• Associated symptoms: nausea, vomiting, bile regurgitation, difficulty swallowing
• Timing of cholecystectomy and whether symptoms began or worsened post-operatively

Past Medical History:

• Previous cholecystectomy (date, indication, complications)
• Diabetes mellitus status
• Obesity/BMI
• H. pylori testing history

Medications:

• Current PPI use and dosing
• NSAID use
• Narcotic medications

Red Flag Symptoms to Assess:

• Unintentional weight loss
• Progressive dysphagia
• Odynophagia
• Persistent vomiting
• GI bleeding (hematemesis, melena)
• Age >55 years (if new-onset symptoms)

Objective

Vital Signs: Temperature, blood pressure, heart rate, respiratory rate, BMI

Physical Examination:

• General: Nutritional status, signs of distress
• Neurological: Cranial nerve examination, sensory testing of face and hands (light touch, pinprick, vibration, proprioception), motor strength, deep tendon reflexes, assess for perioral and acral paresthesias suggesting hypocalcemia or hyperventilation
• Cardiovascular: Rule out cardiac etiology if chest discomfort present
• Abdominal: Epigastric tenderness, surgical scars, hepatomegaly, masses
• Skin: Pallor, jaundice

Pertinent Labs to Consider:

• Complete metabolic panel (calcium, magnesium, glucose)
• Complete blood count
• Liver function tests
• Serum gastrin (if refractory symptoms)
• H. pylori testing (urea breath test or stool antigen) if not previously tested

Assessment

Primary Diagnoses:

1. Gastroesophageal Reflux Disease (GERD) vs. Functional Dyspepsia

• Distinguish predominant symptom: If heartburn/regurgitation predominates = GERD; if epigastric pain/discomfort predominates = dyspepsia 1, 2
• Post-cholecystectomy bile reflux gastropathy: Cholecystectomy is significantly associated with bile reflux gastropathy (OR 6.6) and causes more severe abdominal pain 3, 4. Prevalence of bile reflux gastritis post-cholecystectomy is 61.8% vs. 16.7% in controls 4
• Risk factors present: Obesity and diabetes increase risk of bile reflux gastritis post-cholecystectomy 4

2. Paresthesias - Differential Diagnosis:

• Anxiety/hyperventilation syndrome (commonly associated with GERD symptoms)
• Hypocalcemia (check calcium, magnesium, vitamin D)
• Vitamin B12 deficiency (long-term PPI use)
• Peripheral neuropathy (if diabetic)
• Critical: Rule out cardiac etiology if chest symptoms present

Overlap Consideration:

• GERD/FD overlap occurs in 7.41% of general population; 41.15% of GERD patients have FD symptoms 5

Plan

Diagnostic Approach:

Immediate Management (Age <55, No Alarm Features):

Start empirical PPI therapy for 4-8 weeks 1, 2. This is the recommended first-line approach for troublesome heartburn, regurgitation, or non-cardiac chest pain without alarm symptoms 1.

• Dosing: Once-daily PPI (omeprazole 20-40mg, esomeprazole 40mg, or equivalent) taken 30-60 minutes before breakfast
• If inadequate response after 2-4 weeks: Increase to twice-daily dosing 1
• H. pylori test-and-treat strategy: Perform urea breath test or stool antigen test; if positive, eradicate before continuing PPI 2

Address Paresthesias Concurrently:

• Order: Comprehensive metabolic panel (calcium, magnesium), CBC, B12 level
• If labs normal and symptoms persist: Consider anxiety/hyperventilation as contributing factor
• Do not delay cardiac evaluation if any concern for cardiac etiology

If Symptoms Persist After 4-8 Week PPI Trial:

Endoscopy (EGD) is indicated 1, 2:

• Assess for erosive esophagitis (Los Angeles classification)
• Evaluate for Barrett's esophagus
• Obtain gastric biopsies to document bile reflux gastropathy (foveolar hyperplasia, paucity of inflammation, edema) 3
• Document H. pylori status via biopsy if not previously tested

If EGD shows no erosive disease (LA grade B or greater) or Barrett's:

• Perform 96-hour wireless pH monitoring off PPI (preferred) to confirm GERD phenotype 1
• This distinguishes true GERD from functional heartburn or reflux hypersensitivity

Post-Cholecystectomy Specific Considerations:

Bile reflux gastropathy management:

• PPIs remain first-line despite bile component 3, 4
• Consider adding prokinetic agent (metoclopramide 5-10mg before meals) if symptoms suggest delayed gastric emptying (early satiety, bloating) 6
• Bile acid sequestrants (cholestyramine 4g with meals) can be considered for refractory bile reflux symptoms, though evidence is limited
• Avoid NSAIDs which worsen chemical gastropathy

Refractory Symptoms:

If symptoms persist despite twice-daily PPI and confirmed GERD on testing:

• Add bedtime H2RA (ranitidine alternative: famotidine 20-40mg) for nocturnal symptoms 7
• Consider neuromodulators (tricyclic antidepressants: amitriptyline 10-25mg at bedtime) for visceral hypersensitivity 6, 7
• Evaluate appropriateness of long-term PPI within 12 months of initiation 1

Lifestyle Modifications:

• Weight loss if BMI >25 (particularly important given obesity as risk factor for bile reflux) 4
• Elevate head of bed 6-8 inches
• Avoid late evening meals (3-hour interval before lying down)
• Avoid trigger foods (caffeine, alcohol, chocolate, fatty foods)
• Smoking cessation

Follow-Up:

• 2-4 weeks: Assess response to PPI therapy and review paresthesia workup
• 8 weeks: If no improvement, proceed to EGD
• 12 months: Re-evaluate need for continued PPI therapy if long-term use 1

Patient Education:

• Explain that post-cholecystectomy bile reflux is common (occurs in >60% of patients) and contributes to symptoms 4
• Emphasize PPI safety for GERD treatment 1
• Discuss that paresthesias are likely unrelated to GI symptoms unless metabolic abnormality identified
• Set realistic expectations: symptom improvement rather than complete abolition is typical goal

Red Flags Requiring Urgent Evaluation:

• Progressive dysphagia → immediate EGD
• Unintentional weight loss → immediate EGD
• GI bleeding → immediate evaluation
• Severe persistent chest pain → rule out cardiac etiology first
• Progressive neurological symptoms → neurology referral

This patient requires a dual approach addressing both the post-cholecystectomy GERD/dyspepsia complex and the paresthesias as potentially separate entities, with empirical PPI therapy as the cornerstone of initial management.